Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 EUR | -.--% | -.--% | -40.00% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.89M 4.59M |
---|---|---|---|---|---|
Net income 2021 | -5M -4.69M | Net income 2022 | -5M -4.69M | EV / Sales 2021 | - |
Net cash position 2021 | 6.59M 6.19M | Net cash position 2022 | 3.7M 3.47M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.23
x | P/E ratio 2022 |
-0.87
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.54% |
Current month | +20.00% | ||
1 month | +20.00% | ||
3 months | -40.00% | ||
6 months | -60.00% | ||
Current year | -40.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.006 | -.--% | 0 |
24-04-29 | 0.006 | -.--% | 0 |
24-04-26 | 0.006 | -.--% | 0 |
24-04-25 | 0.006 | -.--% | 0 |
24-04-24 | 0.006 | -.--% | 30,000 |
Real-time Irish S.E., April 30, 2024 at 11:55 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-40.00% | 524K | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- OVXA Stock